Health Affairs October 15, 2021
Aneesh Mehta, John-Martin Lowe, Vikram Mukherjee, Bruce S. Ribner, Shelly Schwedhelm, Lauren Sauer, Melissa Cairo, Sara Imtiaz, Madeline Klineman, Nicole Kunko, Olga Robinson, Andrew M. Wiesenthal

Before the COVID-19 pandemic the U.S. had started to build a national infrastructure to help identify, safely isolate and care for patients with high consequence infectious disease (HCIDs), but it was incomplete. With limited and unsustained investment to build a network to treat patients for a disease like Ebola, the Regional Ebola Treatment Network (RETN) created in 2014 was no match in 2020 for a more transmissible and more widespread pathogen like SARS-CoV-2 otherwise known as COVID-19.

The National Emerging Special Pathogen Training and Education Center (NETEC) and the Regional Ebola and Special Pathogen Treatment Centers (RESPTCs), first established as part of this national infrastructure in the aftermath of the Ebola Virus Disease outbreak, ended up serving as the initial...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
FTC to vote on banning noncompete clauses for physicians, other clinicians and in general
N.C. treasurer backs FTC's bid to block Novant-CHS hospital sale
It's Not Just Congress. There's Plenty of State-Level Action on PBMs, Drug Costs and Prices | AMCP 2024
States ranked by number of practicing surgeons
White House unveils new strategy to prevent future pandemics

Share This Article